Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001766784-24-000002
Filing Date
2024-10-22
Accepted
2024-10-22 14:32:29
Documents
1
Effectiveness Date
2024-10-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10753
  Complete submission text file 0001766784-24-000002.txt   11849
Mailing Address 20 OVERLAND STREET SUITE 520 BOSTON MA 02215
Business Address 20 OVERLAND STREET SUITE 520 BOSTON MA 02215 617-936-0960
Mediar Therapeutics, Inc. (Filer) CIK: 0001766784 (see all company filings)

EIN.: 832874878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-466474 | Film No.: 241385781